JPRN-UMIN000021378招募中未知
Photodynamic therapy using talaporfin sodium in the multidisciplinary therapy for cholangiocarcinoma -safety and efficacy- - The safety and efficacy of photodynamic therapy using talaporfin sodium for cholangiocarcinoma
agoya City University Hospital0 个研究点目标入组 10 人开始时间: 2016年3月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-Hypersensitivity for talaporfin sodium -Uncontrollable infection -Severe psychiatric disorder -Severe comorbidity -Pregnancy
研究者
相似试验
已完成
1 期
Photodynamic diagnosis (PDD) by using Talaporfin and Sie-P2 against local failure after chemoradiotherapy or radiotherapy for esophageal canceresophageal cancerJPRN-UMIN000029734agoya City University Hospital2
已完成
2 期
Photodynamic therapy with half dose verteporfin for central serous chorioretinopathy:Prospective intervention trialCentral serous chorioretinopathyJPRN-UMIN000002229agoya University School of Medicine Department of Ophthalmology10
已完成
不适用
Photodynamic therapy for the palliation of non-resectable proximal cholangiocarcinomaBile duct tumour, cholangiocarcinomaMalignant neoplasm of liver and intrahepatic bile ductsCancerISRCTN43588830Academic Medical Centre (AMC) (Netherlands)75
进行中（未招募）
1 期
Porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: a multicentre, randomised, phase lll study - PHOTOSTENT-02Advanced or metastatic cholangiocarcinomas and other biliary tract tumoursEUCTR2005-001173-96-GBniversity College London240
撤回
2 期
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible LightHigh-grade Dysplasia in Barrett EsophagusNon Small Cell Lung CancerEsophageal CancerNCT01256203Pinnacle Biologics Inc.